CASI - CASI Pharmaceuticals Stock Trading

CASI Pharmaceuticals To Present At Jefferies London Healthcare Conference PR Newswire ROCKVILLE, Md. , and BEIJING , Nov. 15, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and comme...

CASI Pharmaceuticals Announces Third Quarter 2021 Financial Results -EVOMELA Third Quarter 2021 Revenue Continues Strong Upward Trend - - Additional Positive Clinical Data on BI-1206 - - Partner Juventas completed Series C financing round RMB410 million (approximately $6...

CASI Pharmaceuticals Partner, BioInvent, To Present Further Positive Clinical Data On BI-1206 At ASH 2021 ~ BI-1206 restores rituximab activity in relapsed or refractory patients ~~ Demonstrates ORR 50%, DCR 58%, with complete responses lasting beyond 18 and 24 months PR...